KCNJ2 inhibition: a therapeutic target for traumatic brain injury
Drug Target Review,
Using cortical organoids, researchers discovered that targeting KCNJ2 could reduce nerve cell death after TBI.
Using cortical organoids, researchers discovered that targeting KCNJ2 could reduce nerve cell death after TBI.
A team of scientists have utilised lab-grown human brain structures known as organoids to offer insights into why traumatic…
Neurology > General Neurology News and commentary from the world of neurology and neuroscience by Judy George, Deputy Managing…
While an estimated 5 million Americans live with a disability that is related to traumatic brain injury (TBI), there are few…